Amundi
AZN icon

Amundi’s AstraZeneca AZN Stock Holding History

Amundi’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.11B Buy
16,422,784
+1,036,635
+7% +$195M 0.75% 18
2026
Q1 		$3.03B Buy
15,386,149
+15,380,904
+293,249% +$2.97B 0.83% 14
2025
Q4 		$964K Buy
5,245
+63
+1% +$11K ﹤0.01% 1277
2025
Q3 		$886K Buy
5,182
+45
+0.9% +$6.81K ﹤0.01% 1184
2025
Q2 		$731K Buy
5,137
+1,809
+54% +$254K ﹤0.01% 1267
2025
Q1 		$492K Sell
3,328
-12,818
-79% -$1.85M ﹤0.01% 1492
2024
Q4 		$2.15M Sell
16,146
-7,890
-33% -$1.1M ﹤0.01% 1172
2024
Q3 		$3.7M Buy
24,036
+1,608
+7% +$260K ﹤0.01% 1039
2024
Q2 		$3.44M Sell
22,428
-28,958
-56% -$4.36M ﹤0.01% 1017
2024
Q1 		$7.03M Buy
51,386
+12,538
+32% +$1.66M ﹤0.01% 901
2023
Q4 		$5.35M Buy
38,848
+37,335
+2,468% +$4.85M ﹤0.01% 968
2023
Q3 		$204K Sell
1,513
-176,524
-99% -$24.1M ﹤0.01% 1593
2023
Q2 		$23.2M Buy
178,037
+16,931
+11% +$2.49M 0.01% 667
2023
Q1 		$23.2M Buy
161,106
+688
+0.4% +$92.6K 0.01% 677
2022
Q4 		$22.6M Sell
160,418
-2,394
-1% -$300K 0.01% 674
2022
Q3 		$18.5M Sell
162,812
-44,639
-22% -$5.66M 0.01% 710
2022
Q2 		$27M Sell
207,451
-10,156
-5% -$1.33M 0.02% 561
2022
Q1 		$30.9M Buy
217,607
+13,911
+7% +$1.67M 0.02% 569
2021
Q4 		$23.7M Sell
203,696
-130,531
-39% -$15.4M 0.02% 645
2021
Q3 		$40.1M Sell
334,227
-72,433
-18% -$8.43M 0.03% 511
2021
Q2 		$48.7M Buy
+406,660
New +$44.6M 0.03% 449

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Amundi's AZN Position: Q2 2026 in Review

Amundi increased its AstraZeneca (AZN) stake by 6.7% in Q2 2026, buying an estimated $195M and bringing the position to 16,422,784 shares worth $3.11B. The position accounts for 0.75% of the portfolio, ranked #18.

Amundi first reported a position in AZN in Q2 2021 and has held it in 21 quarters since. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Amundi held 16,422,784 shares of AstraZeneca worth $3.11B as of Q2 2026.
  • Amundi bought 1,036,635 AstraZeneca shares in Q2 2026, an estimated $195M.
  • AstraZeneca made up 0.75% of Amundi's portfolio in Q2 2026, its #18 holding.
  • Amundi first reported a position in AstraZeneca in Q2 2021 and has held it in 21 quarters since.
  • 1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.